Phase II study of the anti-ganglioside GD3 mouse/human chimeric antibody KW2871 combined with high dose interferon-a2b in patients with metastatic melanoma.
Stergios J. Moschos
No relevant relationships to disclose
Ahmad A. Tarhini
Consultant or Advisory Role - Genentech; Prometheus
Research Funding - Bristol-Myers Squibb; Merck; Pfizer
Thomas Gajewski
No relevant relationships to disclose
Andrew Mark Scott
No relevant relationships to disclose
Yan Lin
No relevant relationships to disclose
Janice Shipe-Spotloe
No relevant relationships to disclose
Weiping Xu Deblasio
No relevant relationships to disclose
Cindy Sander
No relevant relationships to disclose
Karen Matijevich
No relevant relationships to disclose
Fiona Elizabeth Smyth
No relevant relationships to disclose
Zhanqi Liu
No relevant relationships to disclose
Eric W. Hoffman
Employment or Leadership Position - Ludwig Institute for Cancer Research
Ralph Rudolph Venhaus
Employment or Leadership Position - Ludwig Institute for Cancer Research
Linda S. Pan
Employment or Leadership Position - Ludwig Institute for Cancer Research
Sinhan Tran
Employment or Leadership Position - Ludwig Institute for Cancer Research
James Fiore
Employment or Leadership Position - Life Science Pharmaceuticals
Stock Ownership - Life Science Pharmaceuticals
John M. Kirkwood
No relevant relationships to disclose